Subsidiary of China Meheco Group (600056.SH) passes generic drug consistency evaluation.

China Meheco Group (600056.SH) announced that its wholly-owned subsidiary, Tianfang Pharmaceutical Co., Ltd. ("Tianfang Pharmaceutical"), recently received a Drug Supplementary Application Approval Notice for tranexamic acid injection (referred to as "the drug") issued by the National Medical Products Administration. The drug passed the evaluation of generic drug quality and efficacy consistency. Tranexamic acid injection is mainly used for various types of bleeding caused by acute or chronic, localized or systemic primary fibrinolysis hyperfunction.